ARTICLE | Company News
Prolias Technologies, Cornell University deal
June 25, 2012 7:00 AM UTC
The university granted Prolias Technologies exclusive, worldwide rights to IP related to microRNA diagnostics developed at the Weill Cornell Medical College. The IP includes a miRNA panel to differen...